Home › NDC Lookup › RxCUI directory › RxCUI 861375

Sevelamer carbonate 800 MG Powder for Oral Suspension — RxCUI 861375

RxNorm drug concept · Semantic clinical drug
RxCUI 861375 Semantic clinical drug · SCD ● Current RxNorm concept 20 FDA products 20 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI861375
Official nameSevelamer carbonate 800 MG Powder for Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assevelamer carbonate 0.8 GM Powder for Oral Suspension
FDA products mapped20
Package NDCs mapped20
Reported Medicaid activity (SDUD)10,013 prescriptions · 28 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Sevelamer: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • When your kidneys aren't working properly, they can't remove phosphorus from your blood the way they normally would. Dialysis helps, but it doesn't always bring phosphorus down eno...
  • What exactly does sevelamer do, and why do I need it if I'm on dialysis?
  • Yes, timing really matters here. Sevelamer needs to be taken with each meal because it works by binding to phosphate in the food you're eating right then. If you take it without fo...
  • Does it matter when I take it — can I just take all my doses at once?
📖 Read our full Sevelamer guide →

🕸️ Concept Web — How Sevelamer carbonate 800 MG Powder for Oral Suspe... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Sevelamer carbonate 800 MG Powder for Oral Suspension RxCUI 861375

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Sevelamer 214824
    • Sevelamer carbonate 660890
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Renvela 749207
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Sevelamer Powder for Oral Suspension 1812612
    • Sevelamer carbonate Powder for Oral Suspension 2649266
    • Sevelamer Oral Powder Product 1812611
    • Sevelamer Oral Product 1159078
    • Sevelamer carbonate Oral Powder Product 2662295
    • Sevelamer carbonate Oral Product 2663234
    • Sevelamer Powder for Oral Suspension [Renvela] 1812615
    • Sevelamer carbonate Powder for Oral Suspension [Renvela] 2656825
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Sevelamer carbonate 800 MG SCDC · 749204
  • Sevelamer Powder for Oral Suspension SCDF · 1812612
  • Sevelamer carbonate Powder for Oral Suspension SCDFP · 2649266
  • Sevelamer Oral Powder Product SCDG · 1812611
  • Sevelamer Oral Product SCDG · 1159078
  • Sevelamer carbonate Oral Powder Product SCDGP · 2662295
  • Sevelamer carbonate Oral Product SCDGP · 2663234

Brand-Name Concepts

  • Sevelamer carbonate 800 MG Powder for Oral Suspension [Renvela] SBD · 861377
  • Sevelamer carbonate 800 MG [Renvela] SBDC · 749208
  • Sevelamer Powder for Oral Suspension [Renvela] SBDF · 1812615
  • Sevelamer carbonate Powder for Oral Suspension [Renvela] SBDFP · 2656825
  • Renvela Oral Powder Product SBDG · 1812616
  • Renvela Oral Product SBDG · 1181332
  • Renvela BN · 749207

📦 FDA Products & Package NDCs

20 products · 20 package NDCs
20 package NDCs map to RxCUI 861375 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00115-1365-29 90 PACKET in 1 CARTON (0115-1365-29) / 1 POWDER, FOR SUSPEN... sevelamer carbonate Amneal Pharmaceuticals of New York LLC 2020-11-20
00115-1366-29 90 PACKET in 1 CARTON (0115-1366-29) / 1 POWDER, FOR SUSPEN... sevelamer carbonate Amneal Pharmaceuticals of New York LLC 2020-11-20
00955-1050-27 270 TABLET, FILM COATED in 1 BOTTLE (0955-1050-27) Sevelamer Carbonate Sanofi-Aventis U.S. LLC 2018-02-01
00955-1052-90 90 PACKET in 1 BOX (0955-1052-90) / 1 POWDER, FOR SUSPENSIO... Sevelamer Carbonate Sanofi-Aventis U.S. LLC 2018-01-01
00955-1054-90 90 PACKET in 1 BOX (0955-1054-90) / 1 POWDER, FOR SUSPENSIO... Sevelamer Carbonate Sanofi-Aventis U.S. LLC 2018-01-01
00955-1057-30 270 TABLET, FILM COATED in 1 BOTTLE (0955-1057-30) Sevelamer Carbonate Sanofi-Aventis U.S. LLC 2023-07-14
33342-0288-68 90 PACKET in 1 CARTON (33342-288-68) / 1 POWDER, FOR SUSPEN... SEVELAMER CARBONATE Macleods Pharmaceuticals Limited 2024-04-26
33342-0289-68 90 PACKET in 1 CARTON (33342-289-68) / 1 POWDER, FOR SUSPEN... SEVELAMER CARBONATE Macleods Pharmaceuticals Limited 2024-04-26
43598-0478-90 90 PACKET in 1 CARTON (43598-478-90) / 1 POWDER, FOR SUSPEN... Sevelamer Carbonate for Oral Suspension Dr. Reddys Laboratories Inc 2018-10-25
43598-0479-90 90 PACKET in 1 CARTON (43598-479-90) / 1 POWDER, FOR SUSPEN... Sevelamer Carbonate for Oral Suspension Dr. Reddys Laboratories Inc 2018-10-25
58468-0131-02 90 PACKET in 1 CARTON (58468-0131-2) / 1 POWDER, FOR SUSPEN... Renvela Genzyme Corporation 2009-08-12
58468-0132-02 90 PACKET in 1 CARTON (58468-0132-2) / 1 POWDER, FOR SUSPEN... Renvela Genzyme Corporation 2009-08-12
58468-0133-01 270 TABLET, FILM COATED in 1 BOTTLE (58468-0133-1) Renvela Genzyme Corporation 2023-07-14
64380-0880-80 90 PACKET in 1 CARTON (64380-880-80) / 800 mg in 1 PACKET (... SEVELAMER CARBONATE Strides Pharma Science Limited 2024-02-02
64380-0881-80 90 PACKET in 1 CARTON (64380-881-80) / 2400 mg in 1 PACKET... SEVELAMER CARBONATE Strides Pharma Science Limited 2024-02-02
65862-0930-90 90 POUCH in 1 CARTON (65862-930-90) / 1 POWDER, FOR SUSPENS... SEVELAMER CARBONATE Aurobindo Pharma Limited 2017-06-13
65862-0931-90 90 POUCH in 1 CARTON (65862-931-90) / 1 POWDER, FOR SUSPENS... SEVELAMER CARBONATE Aurobindo Pharma Limited 2017-06-13
69452-0126-19 90 PACKET in 1 CARTON (69452-126-19) / 1 POWDER, FOR SUSPEN... Sevelamer Carbonate Bionpharma Inc. 2021-10-01
69452-0127-19 90 PACKET in 1 CARTON (69452-127-19) / 1 POWDER, FOR SUSPEN... Sevelamer Carbonate Bionpharma Inc. 2021-10-01
72603-0398-02 90 PACKET in 1 CARTON (72603-398-02) / 1 POWDER, FOR SUSPEN... SEVELAMER CARBONATE NorthStar RxLLC 2025-01-01
Observed labelers: Sanofi-Aventis U.S. LLC (4) · Genzyme Corporation (3) · Amneal Pharmaceuticals of New York LLC (2) · Aurobindo Pharma Limited (2) · Bionpharma Inc. (2) · Dr. Reddys Laboratories Inc (2) · +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.